[Application of percutaneous transluminal angioplasty and stent placement at the third hepatic porta in treatment of Budd-Chiari syndrome].
OBJECTIVE
To evaluate percutaneous transluminal angioplasty (PTA) and stent placement at the third hepatic porta in treatment of Budd-Chiari syndrome (BCS).


METHODS
Twenty patients with BCS, 12 males and 8 females, aged 17 to 53, with the main clinical symptom of abdominal distention and mild abdominal pain, were treated with PTA and stent placement: after the identification of the target vessel percutaneous puncture was performed at femoral or jugular vein and rendezvous procedure was used so as to conduct PTA or place a stent. Follow-up was made for 3 - 54 months.


RESULTS
Operation was succeeded in all patients without severe complication with a clinical effective rate of 85%. Symptoms were gradually relieved in 17 cases. Restenosis occurred in 2 cases. One patient died from severe gastric bleeding and one formed thrombosis in the stent.


CONCLUSIONS
A safe and effective new method for diagnosing and treating BCS, PTA and stent placement at the third hepatic porta has the same treatment value for BCS just as the operation at the second hepatic porta.
Gu
Yu-ming
YM
Department of Interventional Therapy, School of Oncology, Peking University, Beijing 100036, China.
Yang
Ren-jie
RJ
D000293:Adolescent; D000328:Adult; D000800:Angioplasty, Balloon / Q000295:instrumentation / Q000379:methods; D006502:Budd-Chiari Syndrome / Q000000981:diagnostic imaging / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006503:Hepatic Veins / Q000000981:diagnostic imaging; D006801:Humans; D008099:Liver / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D011859:Radiography; D015607:Stents; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging